Document 91w9VNq1YJvrQ0oDYygx93XED

p. 1 6 ENVIRONMENT CANADA / HEALTH CANADA CONSULTATION MEETING ACTION PLAN ON PERFLUOROCARBOXYLIC ACIDS (PFCAs) AND PRECURSORS FEBRUARY 6- 7, 2006 HOLIDAY INN, 111 COOPER, OTTAWA ; RAFT AGENDA OBJECTIVE S u To clarify the context for the proposed Action Plan for PFCAs and precursors including : The science behind the proposed Action Pla n The risk assessment and risk management process under the Canadian Environmental Protection Act, 1999 (CEPA 1999 ) u To obtain stakeholder feedback on the proposed Action Plan ROADMA P DAY 1- FEBRUARY 6, 200 6 12 :30 u Coffee, Registration 13 :00 13 :20 14 :15 15 :00 15 :15 16 :00 16 :15 16 :30 A. THE SCIENTIFIC CONTEX T u Welcome / Purpose u Process Review Agenda, how we will work together Anne O'Toole / EC Facilitator u Framing the Science Session Bernard Made/EC u Terminology and Definitions Greg Hammond / EC u Open Forum - Q& A Questions of clarificatio n u A Review of the Science u Health Brea k Derek Muir / EC u Open Forum - Q& A Questions of clarificatio n u New Substances Assessment Reports External Review and Update of the Scienc e Mark Lewis / EC u Wrapping Up Day 1 Agenda revie w Facilitator u End Day 1 000012 p. 2 DAY 2 - FEBRUARY 7, 200 6 08 :00 u Coffee, Light Breakfast B . THE REGULATORY CONTEXT 08 :30 u Getting Started u CEPA 1999 and Risk Assessment/Risk Management An overvie w u Open Forum - Q&A Questions of clarificatio n Facilitator Bernard Made / EC 09 :30 10 :15 10 :30 12 :00 13 :00 15 :00 15 :15 C . PROPOSALS ON PFCAs AND PRECURSORS u The Proposed Action Plan for PFCAs and Precursors An overvie w Greg Hammond / EC u Open Forum - Q&A Questions of clarification u Health Break u Proposed Actions for New Substances Josee Portugais / EC Risk Management Strategy for four fluorotelomer based polymers u Q&A u Discussion Feedback & comments on the proposed Risk Management Strategy u Lunch u Proposed Actions for Existing Substances Early risk management actions on residual s Josee Portugais / EC u Q&A u Discussio n Feedback & comments on the proposed early risk management actions u Health Break u The Research Agenda and International Cooperation Greg Hammond / EC u Q&A 15 :30 16 :00 D . THE PATH FORWAR D u Next Steps Where to from here? Written comments u Closing Comments u End Day 2 Bernard Made / EC 000013